Atlas Trials

Bioequivalence Study of Generic Tretinoin 0.04% Microsphere Gel, 0.04% Retin-A Micro® and Placebo

Clinical trial NCT01243450 · COMPLETED

Trial details

NCT number
NCT01243450
Sponsor
Spear Pharmaceuticals
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
Acne
Start date
2009-10-01
Primary completion
2010-10-01
Enrollment
958

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.